Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.

× No keyword cloud information.

24 in total

Review 1. Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules.

Authors: R Kiessling; K Kono; M Petersson; K Wasserman
Journal: Springer Semin Immunopathol Date: 1996

2. Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients.

Authors: K Itoh; N R Pellis; C M Balch
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

3. Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.

Authors: A P van der Meijden; P A Steerenberg; I M van Hoogstraaten; J A Kerckhaert; L M Schreinemachers; E J Harthoorn-Lasthuizen; A M Hagenaars; W H de Jong; F M Debruijne; E J Ruitenberg
Journal: Cancer Immunol Immunother Date: 1989 Impact factor: 6.968

4. Interleukin 2-activated killer cells: generation in collaboration with interferon gamma and its suppression in cancer patients.

Authors: K Shiiba; R Suzuki; K Kawakami; A Ohuchi; K Kumagai
Journal: Cancer Immunol Immunother Date: 1986 Impact factor: 6.968

Review 5. [The immunology of malignant melanoma (author's transl)].

Authors: G Schieferstein
Journal: Klin Wochenschr Date: 1978-03-15

Review 6. Recurrent and metastatic malignant disease: immunological considerations.

Authors: R L Carter
Journal: Proc R Soc Med Date: 1974-09

7. Diffusion chamber culture of hamster melanoma cells in vivo. Culture characteristics in iso- and heterologous host animals.

Authors: G Schieferstein; O D Laerum
Journal: Arch Dermatol Forsch Date: 1974

Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.